Series C - Sionna Therapeutics - 2024-03-06 - Crunchbase

Mar 6, 2024 · Sionna Therapeutics raised $182000000 on 2024-03-06 in Series C. Enavate Sciences Enavate Sciences is committed to invest in and support the strategic growth of …

CouponFollow Extension

$182000000
OFF

Series C - Sionna Therapeutics - 2024-03-06 - Crunchbase

1 week from now

Mar 6, 2024 · Sionna Therapeutics raised $182000000 on 2024-03-06 in Series C. Enavate Sciences Enavate Sciences is committed to invest in and support the strategic growth of …

crunchbase.com

$182
OFF

Sionna Therapeutics Announces $182 Million Series C Financing To ...

1 week from now

Boston, MA, March 6, 2024 — Sionna Therapeutics, a clinical-stage life sciences company dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF), …

sionnatx.com

$182
OFF

Sionna Therapeutics Announces $182 Million Series C Financing To ...

1 week from now

Mar 6, 2024 · Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis PR Newswire Wed, Mar 6, …

yahoo.com

$182
OFF

Sionna Closes $182M Series C In Potential Cystic Fibrosis

1 week from now

Mar 6, 2024 · Pictured: A young boy with an oxygen mask/ iStock, Anastasia Dobrusina Massachusetts-based Sionna Therapeutics announced Wednesday that it has capped off …

biospace.com

$182
OFF

Sionna Therapeutics Completes $182 Million Series C

1 week from now

Mar 7, 2024 · The Life Sciences team advised Sionna Therapeutics on the closing of its $182 million Series C financing round. The round was led by Enavate Sciences, which invests in …

goodwinlaw.com

$182
OFF

Sionna Therapeutics Raises $182M In Series C Financing - FinSMEs

1 week from now

Mar 7, 2024 · Sionna Therapeutics, a Boston, MA-based clinical-stage life sciences company, raised $182M in Series C funding ... Sionna Therapeutics Raises $182M in Series C …

finsmes.com

$182
OFF

Sionna Therapeutics Announces $182 Million Series C Financing To ...

1 week from now

Mar 6, 2024 · Sionna has nominated two additional NBD1 stabilizers from its second series, SION-451 and SION-719, and plans to advance both compounds to clinical trials in 2024 …

prnewswire.com

$182
OFF

Sionna Therapeutics Secures $182 Million In Series C Funding For …

1 week from now

Mar 6, 2024 · Sionna Therapeutics, a clinical-stage life sciences company focused on developing innovative treatments for cystic fibrosis (CF), has successfully closed a $182 million Series C …

siliconvalleyjournals.com

$182
OFF

Sionna Therapeutics Announces $182 Million Series C

1 week from now

Mar 6, 2024 · Sionna Therapeutics, a clinical-stage life sciences company dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF), announced the …

vcnewsdaily.com

$182
OFF

Sionna Raises Another $182M To Challenge Vertex In Cystic Fibrosis

1 week from now

Mar 6, 2024 · Sionna Therapeutics, a Waltham, Massachusetts biotechnology startup, announced Wednesday it raised a $182 million Series C round to advance a group of experimental drugs …

biopharmadive.com

$182
OFF

Sionna Raises $182M For Cystic Fibrosis Drugs Different From …

1 week from now

Mar 6, 2024 · Sionna Therapeutics has raised $182 million in a Series C to test its small molecules for cystic fibrosis by targeting the mutated region of the protein at the root of ...

endpts.com

$182
OFF

Sionna Therapeutics Announces $182 Million Series C Financing To ...

1 week from now

Mar 6, 2024 · Sionna Therapeutics announced the closing of a $182 million Series C financing to support the clinical development of first-in-class small molecules designed to fully restore the …

biospace.com

$182
OFF

Sionna Raises $182 Million To Advance Novel Small ... - Global Genes

1 week from now

March 6, 2024 Rare Daily Staff Sionna Therapeutics, a clinical-stage company developing differentiated treatments for cystic fibrosis, closed a $182 million series C financing to support …

globalgenes.org

$182
OFF

Sionna Therapeutics Announces $182 Million Series C Financing To ...

1 week from now

BOSTON, March 6, 2024-- Sionna Therapeutics, a clinical-stage life sciences company dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF), today …

vcaonline.com

$182
OFF

Sionna Therapeutics Announces $182 Million Series C Financing To ...

1 week from now

Mar 6, 2024 · Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis PR Newswire - Company …

investorsobserver.com

FAQs about Series C - Sionna Therapeutics - 2024-03-06 - Crunchbase Coupon?

How much money did Sionna raise in 2024?

Sionna emerged from stealth back in 2022 and announced it had already amassed $150 million in venture capital, of which $111 million was raised in a Series B round. Only two U.S. companies have announced a larger Series C fundraising than Sionna so far in 2024, according to Crunchbase data. ...

Is Sionna chasing vertex in the cystic fibrosis market?

Sionna's new financing adds momentum to its chase of Vertex in the cystic fibrosis market. (PaulGregg/iStock/Getty Images Plus) Sionna Therapeutics has closed a $182 million series C, enough to last through 2026 and more than double the number of cystic fibrosis treatments in clinical development. ...

Why is Sionna developing small molecules for cystic fibrosis?

Sionna is developing small molecules to fully restore function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. CEO Mike Cloonan said CF is caused by mutations in the CFTR protein, which results in mucus not flowing freely throughout the body. ...

Is Sionna preparing a new NBD1 stabilizer?

Sionna has nominated two additional NBD1 stabilizers from its second series, SION-451 and SION-719, and plans to advance both compounds to clinical trials in 2024 pending results from ongoing Good Laboratory Practice (GLP) toxicology studies. ...